Market Newsdesk

Nebius announces agreement to acquire Tavily to add agentic search to its AI cloud platform

• Acquisition extends Nebius’s cloud platform capabilities with real-time search infrastructure for AI agents

• Addresses critical capability in fast-growing agentic AI market to capture multibillion-dollar opportunity

AMSTERDAM–(BUSINESS WIRE)–
Nebius (NASDAQ: NBIS), the AI cloud company, today announced an agreement to acquire Tavily, a leading agentic search provider serving Fortune 500 enterprises and top AI companies. The deal brings real-time search infrastructure into Nebius’s AI cloud platform as the agentic AI market enters a period of rapid enterprise adoption.

This acquisition advances Nebius’s strategy to build a unified platform where vertical AI companies and enterprises can build, tune, and run autonomous agents. By adding Tavily’s agentic search to its existing AI cloud platform, Nebius is expanding the integrated software stack developers need to assemble and operate enterprise-grade agentic systems.

Tavily’s technology becomes a critical component of this stack, complementing Nebius Token Factory. While Token Factory provides the high-performance inference required for agents to reason, Tavily provides the real-time web access required for factual accuracy. By combining high-performance inference with real-time grounding, Nebius provides the essential building blocks for the next generation of AI applications.

The addition of agentic search capabilities gives Nebius customers critical architecture they need to build autonomous agents that can navigate the web, verify facts, and execute complex real-world tasks, while eliminating the need for developers to patch together disparate vendors.

Roman Chernin, co-founder and Chief Business Officer of Nebius, said:

“We’re not just an infrastructure-as-a-service company — we’re building the complete platform for anyone who wants to build AI products, agents, or services. Tavily is solving a critical part of this stack with agentic search and has proven it with strong developer adoption. This acquisition brings the search layer directly into our stack, so developers can focus on their applications instead of managing multiple vendors. Our strategy is clear: provide an open platform that serves everyone from startups to the largest enterprises, giving them the tools to own their AI destiny.”

The Tavily team, including founder and CEO Rotem Weiss, will join Nebius and continue leading development of the Tavily product. Tavily will continue operating under its current brand, serving existing customers and developing new capabilities while leveraging Nebius’s global infrastructure and engineering resources.

Rotem Weiss, founder and CEO of Tavily, said:

“Tavily is on a mission to onboard the next billion AI agents to the web. Agentic search is a multi-billion-dollar opportunity, and we believe the market is poised to grow exponentially as enterprises deploy autonomous AI systems. Joining forces with Nebius, one of the world’s premier deep-tech engineering teams, accelerates our ability to scale globally and enables us to push the boundaries of what’s possible further and faster.”

The agentic AI market is projected to grow from approximately $7 billion in 2025 to between $140 billion and $200 billion by the early 2030s, representing a compound annual growth rate exceeding 40%.¹ Within this landscape, agentic search infrastructure represents a critical enterprise capability: industry forecasts indicate AI agents will issue more internet queries than humans within the next few years.

Tavily has demonstrated strong product-market fit with over 3 million monthly SDK downloads achieved through organic, developer-led growth. With a developer community of more than one million users, Tavily serves Fortune 500 enterprises including IBM, alongside leading AI companies such as Cohere and Groq, powering mission-critical applications across industries including financial services, logistics, and enterprise operations.

The transaction is expected to close in the next few weeks, subject to customary closing conditions. The transaction value has not been disclosed.

¹ E.g. Precedence Research, “Agentic AI Market Size to Hit USD 199.05 Billion by 2034” (December 2025).

About Nebius

Nebius, the AI cloud company, is building the full-stack platform for developers and companies to take charge of their AI future — from data and model training to production deployment. Founded on deep in-house technological expertise and operating at scale with a rapidly expanding global footprint, Nebius serves startups and enterprises building AI products, agents, and services worldwide. Nebius is listed on Nasdaq (NASDAQ: NBIS) and headquartered in Amsterdam. For more information please visit www.nebius.com

Forward Looking Statements

This document contains forward-looking statements that involve risks and uncertainties. All statements contained or implied other than statements of historical facts, including, without limitation, statements regarding our business plans, market opportunities, capital expenditure requirements, financing requirements and projected financial performance, are forward-looking statements. In some cases, these forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. In addition, these forward-looking statements reflect our current views with respect to future events and are not a guarantee of future performance. The potential risks and uncertainties that could cause actual results to differ from the results predicted or implied by such statements include, among others, our ability to successfully compete in our sector; to implement our business plans; to continue to successfully capture customers; to continue to successfully obtain required supplies of hardware on acceptable terms; to successfully integrate acquired businesses and technologies; and to obtain further debt or equity financing that may be necessary to achieve our objectives on acceptable terms. Many of these risks and uncertainties depend on the actions of third parties and are largely outside of our control. We also continue to be subject to many of the risks and uncertainties included under the captions “Risk Factors” and “Operating and Financial Review and Prospects” in our Annual Report on Form 20-F for the year ended December 31, 2024 filed with the U.S. Securities and Exchange Commission (“SEC”) on April 30, 2025, which are available on our investor relations website at https://nebius.com/ and on the SEC website at www.sec.gov. All information in this document is as of the date hereof, and the Company undertakes no duty to update this information unless required by law.

In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this document, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely upon these statements.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260210002813/en/

Investor Relations: [email protected]

Media Relations: [email protected]

KEYWORDS: Netherlands Europe

INDUSTRY KEYWORDS: Software Technology Artificial Intelligence Data Management

MEDIA:

Posted on February 10, 2026 10:34 am

VEON’s Kyivstar Expands Digital Healthcare Services in Ukraine with Tabletki.ua Acquisition

Dubai, Kyiv and New York, February 10, 202
6 – VEON Ltd. (Nasdaq: VEON) (“VEON”), a global digital operator, announces that today its subsidiary Kyivstar Group Ltd. (“Kyivstar”) (Nasdaq: KYIV; KYIVW) signed a definitive agreement and completed the transaction to acquire 100% of Tabletki.ua for USD 160 million, payable in Ukrainian hryvna in Ukraine. Tabletki.ua is one of Ukraine’s most widely used digital platforms for finding, comparing and reserving medicines and other products available at Ukrainian pharmacies.

Tabletki.ua is trusted by millions of users every month and is Ukraine’s preferred digital platform for accessing prescriptions as well as other medicinal and nutritional health products. The platform enables customers to quickly find, compare, and reserve prescribed and over-the-counter medicines and healthcare products available at pharmacies nationwide, ensuring availability, transparent pricing, and convenient access to essential healthcare products.

Tabletki.ua partners with more than 14,000 pharmacies across Ukraine and facilitated an average of 14 million reservations per month in 2025, reflecting its role as an everyday healthcare tool for Ukrainian families. Gross merchandise value (GMV) of bookings via the platform reached UAH 45 billion (USD 1.06 billion) in FY2024 and UAH 57.3 billion (USD 1.19 billion) for the last twelve months ending September 30, 2025.

The acquisition strengthens Kyivstar’s growing healthcare ecosystem, complementing its earlier acquisition of the digital healthcare platform Helsi in 2022. Tabletki.ua will become part of Kyivstar’s expanding portfolio of digital services, which also includes ride-hailing and delivery platform Uklon, Kyivstar TV, and the MyKyivstar super-app.

“Ukrainian businesses like Tabletki.ua are enabling millions of Ukrainians to benefit from convenient, digital-first solutions, supporting the growth and resilience of the country,” saidOleksander Komarov, President of Kyivstar. “Tabletki.ua already plays an essential role in everyday life for millions of Ukrainians. By combining Kyivstar’s experience in building and scaling digital platforms with Tabletki.ua’s strong market position, we will make healthcare services even more accessible and convenient across Ukraine.”

“This acquisition strengthens our commitment to Ukraine by expanding access to digital healthcare solutions that improve everyday life,” said Kaan Terzioglu, VEON Group CEO and Executive Chairman of Kyivstar. “Together, Kyivstar and Tabletki.ua will accelerate the development of innovative, customer-focused healthcare services.”

Based on unaudited management accounts, Tabletki.ua generated LTM EBITDA of USD 24 million and LTM net profit of USD 20 million as of September 30, 2025. The agreed consideration of USD 160 million corresponds to a price to LTM earnings ratio of 8.0X.

Today, VEON also published a presentation for investors that provides further information about Tabletki.ua and the strategic rationale for the acquisition. The presentation is available on the VEON website here.

About Kyivstar
Group Ltd.

Kyivstar Group Ltd. (“Kyivstar”) is a Nasdaq-listed holding company that operates JSC Kyivstar, Ukraine’s leading digital operator and the first Ukrainian company to list on a U.S. stock exchange. Kyivstar’s companies provide a broad range of connectivity and digital services, including mobile and fixed-line voice and data, ride-hailing, e-health, digital TV, and enterprise solutions such as Big Data, cloud, and cybersecurity.

Together with VEON, Kyivstar intends to invest USD 1 billion in Ukraine between 2023-2027, through investments in infrastructure, technological development and strategic acquisitions, as well as charitable donations for social projects.

For more information, please visit https://investors.kyivstar.ua.  

Nasdaq tickers: KYIV; KYIVW

About VEON

VEON is a digital operator that provides connectivity and digital services to nearly 150 million connectivity customers and over 140 million digital users. Operating across five countries that are home to more than 6% of the world’s population, VEON is transforming lives through technology-driven services that empower individuals and drive economic growth. VEON is listed on NASDAQ. For more information, visit: www.veon.com. 

Forward-Looking Statements

This release contains “forward-looking statements”, within the meaning of the Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Such forward-looking statements include, but are not limited to, the closing of Kyivstar’s acquisition of Tabletki.ua, the expected impact of the acquisition for VEON, and the expected financial performance of VEON post the acquisition. There are numerous risks, uncertainties that could cause actual results and performance to differ materially from those expressed by such statements, including risks relating the closing of Kyivstar’s acquisition of Tabletki.ua, the expected impact of the acquisition for VEON, the expected financial performance of VEON post the acquisition, as well as VEON’s ability to achieve anticipated results and business objectives, among others discussed in the section entitled “Risk Factors” in VEON’s 2024 Form 20-F filed with the SEC on April 25, 2025 and other public filings made by VEON with the SEC. The forward-looking statements contained herein speak only as of the date of this release and VEON disclaims any obligation to update them, except as required by law. VEON disclaims any obligation to update or revise any forward-looking statements contained in this press release, other than to the extent required by applicable law.

Additionally, this press release includes certain financial information and data of Tabletki.ua derived from preliminary, unaudited management accounts as of the dates indicated and is subject to completion of customary financial closing, review, and audit procedures. This information is provided for informational purposes only and should not be regarded as a complete statement of financial results or relied upon as necessarily indicative of historical or future performance.

Contact Information

VEON 

Hande Asik
Chief Communications and Strategy Officer
[email protected]

Posted on February 10, 2026 10:33 am

Kyivstar to Expand Digital Healthcare Offering in Ukraine with Tabletki.ua Acquisition

KYIV, Ukraine, Feb. 10, 2026 (GLOBE NEWSWIRE) — Kyivstar Group Ltd. (Nasdaq: KYIV; KYIVW) (“Kyivstar”), Ukraine’s leading digital operator and the first Ukrainian company to trade on the Nasdaq, has today signed a definitive agreement and completed the transaction to acquire 100% of Tabletki.ua for a consideration of USD 160 million, which will be paid in full in Ukrainian hryvna in Ukraine. Tabletki.ua is one of Ukraine’s most widely used digital marketplaces for healthcare products that enables consumers to find, compare, and book medicines and other products at Ukrainian pharmacies.

Tabletki.ua facilitates customers’ access to medicines and healthcare, as well as nutrition and consumer products, aggregating data on the availability and pricing of medicines, medical devices and more. Tabletki.ua joins Kyivstar’s widening portfolio of digital services, including digital healthcare platform Helsi, ride-hailing and delivery service Uklon, digital media platform Kyivstar TV and the MyKyivstar superapp.

“Even in challenging times, Ukrainian businesses like Tabletki.ua are enabling millions of Ukrainians to benefit from convenient, digital-first solutions, supporting the growth and resilience of the country,” said Oleksander Komarov, President of Kyivstar. “Tabletki.ua already plays a vital role in everyday life for millions of Ukrainians This acquisition will allow us to combine Kyivstar’s successful track record of running and growing digital businesses with Tabletki.ua’s solid foundations to expand digital healthcare to a wider customer base and offer more convenience for all.”

Tabletki.ua partners with more than 14,000 pharmacies across Ukraine, and facilitated an average of 14 million online bookings per month in 2025, reflecting its role as a trusted, everyday healthcare tool for Ukrainian families. The gross merchandise value (GMV) of bookings facilitated through the platform amounted to UAH 45 billion (USD 1,056 million) for FY2024 and UAH 57.3 billion (USD 1,191 million) for the last 12 months (“LTM”) ending September 30, 2025.

Based on unaudited management accounts, Tabletki.ua generated LTM EBITDA of USD 24 million and LTM net profit of USD 20 million as of September 30, 2025. The agreed consideration of USD 160 million corresponds to a price to LTM earnings (PE) ratio of 8.0X.

Today, Kyivstar also published a presentation for investors that provides further information about Tabletki.ua and the strategic rationale for the acquisition. The presentation is available on the Kyivstar website here: https://investors.kyivstar.ua/static-files/4695eb4f-e085-4a5e-bad6-f4fc71d51d87

About Kyivstar Group Ltd.

Kyivstar Group Ltd. (“Kyivstar”) is a Nasdaq-listed holding company that operates JSC Kyivstar, Ukraine’s leading digital operator and the first Ukrainian company to list on a U.S. stock exchange.Kyivstar’s companies provide a broad range of connectivity and digital services, including mobile and fixed-line voice and data, ride-hailing, e-health, digital TV, and enterprise solutions such as Big Data, cloud, and cybersecurity.

Together with VEON, Kyivstar intends to invest USD 1 billion in Ukraine between 2023-2027, through investments in infrastructure, technological development and strategic acquisitions, as well as charitable donations for social projects.

For more information, please visit


https://investors.kyivstar.ua



.

Nasdaq tickers: KYIV; KYIVW

About JSC Kyivstar

JSC Kyivstar is Ukraine’s leading digital operator, serving more than 22.5 million mobile customers and over 1.2 million home internet fixed line customers as of September 30, 2025. The company provides services using a wide range of mobile and fixed technologies, including 4G, Big Data, cloud solutions, cybersecurity services, digital TV, and more. JSC Kyivstar is advancing new telecommunication technologies in Ukraine and together with VEON plans to invest USD 1 billion in this direction between 2023-2027.

JSC Kyivstar is wholly owned by Kyivstar Group Ltd. (Nasdaq: KYIV; KYIVW), the first Ukrainian company to have its shares traded on the U.S. stock exchange Nasdaq.

The company contributes to overcoming the challenges of wartime and, over the past three years, has allocated over UAH 3.4 billion to support the Defense Forces, its subscribers, and the implementation of social projects. JSC Kyivstar has operated in Ukraine for 27 years and is recognized as the largest taxpayer in the digital communications market, a top employer, and a socially responsible company.

Additional information: [email protected], www.kyivstar.ua.

Disclaimer

This press release contains “forward-looking statements,” as the phrase is defined in Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Such forward-looking statements include, but are not limited to, statements relating to, among other things, the closing of Kyivstar’s acquisition of Tabletki.ua, the expected impact of the acquisition for Kyivstar Group and the expected financial performance of Kyivstar Group post the acquisition. There are numerous risks and uncertainties that could cause actual results and performance to differ materially from those expressed by such statements, including risks relating to the closing of Kyivstar’s acquisition of Tabletki.ua, the expected impact of the acquisition for Kyivstar Group, the expected financial performance of Kyivstar Group post the acquisition, as well as Kyivstar’s ability to achieve anticipated results and business objectives, among others discussed in the section entitled “Risk Factors” included in the final prospectus filed by Kyivstar with the U.S. Securities and exchange Commission (“SEC”) on January 30 , 2025, as amended and supplemented from time to time, and in any other subsequent filings with the SEC by Kyivstar. Kyivstar disclaims any obligation to update or revise any forward-loooking statements contained in this press release, other than to the extent required by applicable law.

Additionally, this press release includes certain financial information and data of Tabletki. derived from preliminary, unaudited management accounts as of the dates indicated and is subject to completion of customary financial closing, review, and audit procedures. This information is provided for informational purposes only and should not be regarded as a complete statement of financial results or relied upon as necessarily indicative of historical or future performance.        

Posted on February 10, 2026 10:18 am

Interactive Brokers Expands Crypto Futures Offering with Coinbase Derivatives

Interactive Brokers Expands Crypto Futures Offering with Coinbase Derivatives

Select nano and Perpetual Style Futures Contracts Available Around the Clock

GREENWICH, Conn.–(BUSINESS WIRE)–Interactive Brokers (Nasdaq: IBKR), an automated global electronic broker, today announced the launch of Coinbase Derivatives, LLC nano Bitcoin and nano Ether futures contracts for trading on the IBKR platform. These new products are available with monthly expirations or as perpetual-style contracts, offering eligible clients a cost-effective way to gain exposure to cryptocurrency and manage risk within a regulated framework, with trading available 24/7.

Clients of Interactive Brokers can access more than 170 markets worldwide and trade both traditional instruments and digital assets from a single platform. The new Coinbase Derivatives contracts offer an easier way to manage cryptocurrency exposure, with lower capital requirements and transparent trading on a regulated exchange.

Nano futures are smaller-sized contracts, such as 0.01 Bitcoin and 0.10 Ether, that lower entry costs and allow for more precise position sizing. Perpetual-style futures are long-dated contracts that are designed to closely track the spot price of the cryptocurrency, reducing the need to frequently roll contracts. Together, nano contract sizing and perpetual-style features make these futures products more accessible and convenient for a wide range of traders.

“Perpetual-style crypto futures have become popular with traders because they provide long-dated exposure and greater flexibility,” said Milan Galik, Chief Executive Officer of Interactive Brokers. “By offering nano-sized Bitcoin and Ether futures on a regulated exchange, we are expanding access to these products with smaller contract sizes and lower margin requirements, alongside the broad range of global markets available on our platform.”

“We’re pleased to collaborate with Interactive Brokers to expand access to regulated crypto derivatives,” said Greg Tusar, Co-CEO of Coinbase Institutional. “These nano sized contracts are designed to lower the barrier to entry and give more investors the ability to engage with digital assets in a secure and regulated environment.”

Eligibility to trade in crypto-related products may vary based on jurisdiction.

To learn more about trading Coinbase Crypto futures with Interactive Brokers, visit:

US and countries served by IB LLC: Coinbase Derivatives

Canada: Coinbase Derivatives

Europe: Coinbase Derivatives

Australia: Coinbase Derivatives

Hong Kong: Coinbase Derivatives

Singapore: Coinbase Derivatives

Coinbase Derivatives trade 24/7 except for Fridays, 17:00 – 18:00 Eastern for scheduled exchange maintenance.

The best-informed investors choose Interactive Brokers

About Interactive Brokers Group, Inc.:

Interactive Brokers Group, Inc. (NASDAQ: IBKR) is a member of the S&P 500. Its affiliates provide automated trade execution and custody of securities, commodities, foreign exchange, and forecast contracts around the clock on over 170 markets in numerous countries and currencies from a single unified platform to clients worldwide. We serve individual investors, hedge funds, proprietary trading groups, financial advisors and introducing brokers. Our four decades of focus on technology and automation have enabled us to equip our clients with a uniquely sophisticated platform to manage their investment portfolios. We strive to provide our clients with advantageous execution prices and trading, risk and portfolio management tools, research facilities and investment products, all at low or no cost, positioning them to achieve superior returns on investments. Interactive Brokers has consistently earned recognition as a top broker, garnering multiple awards and accolades from respected industry sources such as Barron’s, Investopedia, Stockbrokers.com, and many others.

Follow Interactive Brokers on social media:

US and World (except Europe): Facebook, Instagram, LinkedIn, X, YouTube, TikTok

UK and Europe: Facebook, Instagram, X, TikTok

View source version on businesswire.com: https://www.businesswire.com/news/home/20260210379285/en/

Contacts for Interactive Brokers Group, Inc. Media: Katherine Ewert, [email protected]

 

KEYWORDS: Connecticut Southeast Asia Latin America Australia Singapore North America Asia Pacific United States Australia/Oceania

INDUSTRY KEYWORDS: Finance Cryptocurrency Banking Professional Services Asset Management

MEDIA:

Logo

New Sensodyne Clinical Repair Toothpaste Launches with Breakthrough Formula for Rapid, Clinically Proven Sensitivity Relief

The breakthrough formula starts to repair sensitive areas of teeth after 60 seconds for substantial sensitivity relief in 3 days, delivering long-lasting relief with twice-daily brushing

Key Takeaways

• Sensodyne unveils Clinical Repair, the brand’s newest toothpaste option for sensitive teeth.

• Clinical Repair:
  • Starts to repair sensitive areas of teeth after 60 seconds* for clinically proven long-lasting relief**.

  • With twice daily brushing, Clinical Repair generates a protective layer that restrengthens with every use – protecting against sensitivity returning**

  • Designed to target and strengthen enamel, addressing sensitivity at the source.

• Developed with a science-backed formula that delivers clinical efficacy with a clean, refreshing feel and an enjoyably minty brushing experience across two options:
  • Whiten & Shine: A cool, arctic mint blend of peppermint and spearmint

  • Fresh Clean: Rich, refreshing mix of peppermint and eucalyptus

WARREN, N.J.–(BUSINESS WIRE)–
The No. 1 dentist-recommended brand for sensitive teeth has launched Sensodyne Clinical Repair, its newest option for sensitive teeth, a toothpaste designed to address the root cause of tooth sensitivity. Based on data showing that 85% of people with sensitive teeth want solutions that repair sensitivity by addressing the root cause of their pain, Sensodyne developed Clinical Repair to go beyond temporary relief and actively repair sensitive areas of teeth with continued use.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210680667/en/

Tooth sensitivity affects millions of adults and can make everyday moments – from enjoying hot drinks to savoring cold treats – uncomfortable or painful. Powered by a scientifically backed formula, Sensodyne Clinical Repair starts to repair sensitive areas of teeth after 60 seconds*, forming a protective layer that restrengthens with every use to deliver clinically proven, long-lasting relief from sensitivity.

“Oral care is a daily essential in any personal care routine, yet for those with vulnerable, sensitive teeth, even simple moments can feel uncomfortable, from sipping a hot coffee in the morning to smiling with confidence,” said Rishi Mulgund, Senior Director of Sensodyne in the US. “People with sensitive teeth aren’t looking for short-term fixes. They want care they can trust to help protect sensitive teeth at the source, which is why we created Sensodyne Clinical Repair.”

Innovative Repair Technology, Backed by Science

Sensodyne Clinical Repair features a formula that stays stable until brushing begins, when it’s activated by saliva. Once activated, it forms a protective layer over sensitive areas of teeth. With twice-daily brushing, this layer restrengthens with every use, protecting against sensitivity returning, all without changing your everyday brushing routine.

In clinical studies, Sensodyne Clinical Repair created a protective layer that was harder and offered more complete coverage than two leading competitors, raising the bar in sensitivity repair.

Two Options Designed for Everyday Oral Care Needs

Sensodyne Clinical Repair is designed to fit seamlessly into daily routines, helping people protect sensitive teeth while delivering cleaning and whitening benefits. The toothpaste is available in two refreshing options, now in a new blue color:

• Sensodyne Clinical Repair Whiten & Shine: Formulated for people who want sensitivity relief and a brighter smile. Whiten & Shine provides repair-focused sensitivity relief alongside superior whitening from stain removal. A cool, arctic mint blend of peppermint and spearmint leaves the mouth feeling fresh and polished.

• Sensodyne Clinical Repair Fresh Clean: Designed for those who want a deep clean and long-lasting freshness. Fresh Clean delivers gentle, repair-focused sensitivity relief with cleaning action through stain removal, featuring a rich, foaming formula and a refreshing blend of peppermint and eucalyptus for a just-brushed feeling that lasts.

Built for Modern Routines

As personal care routines become more intentional and performance-driven, Sensodyne Clinical Repair is designed to fit seamlessly into everyday brushing, delivering fast, reliable protection without compromise. Its clinically proven repair technology provides substantial sensitivity relief in as little as three days**, while continuing to strengthen protection with ongoing use.

Pricing & Availability

Sensodyne Clinical Repair is now available at leading retailers, such as Amazon, Walmart, and Target, and nationwide soon, with an MSRP of $8.99.

For more information about Sensodyne Clinical Repair, visit www.sensodyne.com.

* for substantial sensitivity relief in three days

** with twice-daily brushing

** with continued twice daily brushing

About Sensodyne

Sensodyne is the No. 1 dentist-recommended brand for sensitive teeth and has been trusted by consumers worldwide for decades. With a commitment to science-backed innovation, Sensodyne continues to advance oral health solutions designed to help people live more comfortably, every day.

About Haleon US

Haleon (NYSE: HLN) is a leading global consumer health company with a purpose to deliver better everyday health with humanity. Haleon’s product portfolio spans six major categories: Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health. Built on trusted science, innovation, and deep human understanding, Haleon’s U.S. brands include Abreva, Advil, Benefiber, Centrum, Emergen-C, Excedrin, Flonase, Gas-X, Nexium, Nicorette, Parodontax, Polident, Preparation H, Pronamel, Sensodyne, Robitussin, Theraflu, TUMS, Voltaren, and more. For more information on Haleon and its brands, please visit www.haleon.com or contact [email protected].

View source version on businesswire.com: https://www.businesswire.com/news/home/20260210680667/en/

MEDIA CONTACTS


Susana Pastrana

[email protected]

KEYWORDS: United States North America New Jersey

INDUSTRY KEYWORDS: General Health Other Consumer Consumer Health Dental

MEDIA:

Photo

Photo

Photo

Logo

Belden Taps Industry 4.0’s Leading Voice, Jeff Winter, to Shape Commercial Strategy

Global Industry 4.0 influencer joins as Vice President of Commercial Strategy, will maintain independent voice while shaping Belden’s commercial transformation

ST. LOUIS–(BUSINESS WIRE)–
Belden Inc. (NYSE: BDC), a leading global provider of complete connection solutions, today announced that Jeff Winter has joined the company as Vice President of Commercial Strategy.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210203308/en/

In his new role, Winter will help shape and lead Belden’s commercial strategy while expanding technical capabilities and credibility across its core markets. His deep expertise and influence within Industry 4.0 brings additional depth and mastery to Belden’s already industry-leading IT/OT convergence solutions.

“Jeff helps manufacturers navigate the complexity of digital transformation with clarity and authenticity, which has earned him the trust of industry leaders worldwide,” said Brian Lieser, Executive Vice President and Chief Commercial Officer. “As we endeavor to expand the value we offer to Belden customers, Jeff’s ability to connect strategy to real-world outcomes will be invaluable.”

Winter is widely recognized as one of the leading independent voices in industrial automation, AI and manufacturing. He has been named a top expert in the field more than 25 times, including ranking as the number one global thought leader for Industry 4.0 by Onalytica and number one global influencer in manufacturing by Manufacturing Digital Magazine.

Winter brings over two decades of manufacturing industry experience spanning automation, controls and digital transformation. He has held senior roles at Microsoft, Hitachi Solutions, Omron Automation and Critical Manufacturing, where he advised multi-billion-dollar manufacturers on their digital transformation strategies. He also serves on the international board of directors of both the Manufacturing Enterprise Solutions Association (MESA) and the International Society of Automation (ISA) and is a U.S.-registered expert for the International Electrotechnical Commission (IEC).

“I’ve spent my career helping leaders understand not just what’s possible in modern manufacturing, but what it takes — organizationally, technically, and culturally — to make it real,” said Winter. “Belden is doing exactly what I’ve been advocating for: building the infrastructure that makes Industry 4.0 practical, not just possible. I’m excited to shape that strategy while continuing to serve the broader industrial community as an independent voice.”

Winter’s addition signals Belden’s commitment to leading the Industry 4.0 conversation, not just participating in it, as the company continues its transformation into a comprehensive solutions provider.

About Belden

Belden Inc. delivers complete connection solutions that unlock untold possibilities for our customers, their customers and the world. We advance ideas and technologies that enable a safer, smarter and more prosperous future. Throughout our 120+ year history, we have evolved as a company, but our purpose remains – making connections. By connecting people, information and ideas, we make it possible. We are headquartered in St. Louis and have manufacturing capabilities in North America, Europe, Asia and Africa. For more information, visit us at www.belden.com; follow us on Facebook, LinkedIn and X/Twitter.

Belden and the Belden logo are trademarks or registered trademarks of Belden Inc. or its affiliated companies in the United States and other jurisdictions. Belden and other parties may also have trademark rights in other terms used herein.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260210203308/en/

For more information, contact:

Scott Todd

Manager, Public Relations and Thought Leadership

+1.317.316.6473

[email protected]

KEYWORDS: Missouri United States North America

INDUSTRY KEYWORDS: Technology Mobile/Wireless Semiconductor Security Telecommunications Audio/Video Hardware Electronic Design Automation Consumer Electronics

MEDIA:

Photo

Belden welcomes Jeff Winter as VP, Commercial Strategy

Logo

Zebra Technologies to Present at the Citi Global Industrial Tech & Mobility Conference

LINCOLNSHIRE, Ill.–(BUSINESS WIRE)–Zebra Technologies Corporation (NASDAQ: ZBRA), a global leader in digitizing and automating workflows to deliver intelligent operations, today announced that the company will present at the Citi Global Industrial Tech & Mobility Conference in Miami, on Tues., Feb. 17 at 8:00 a.m. U.S. eastern time.

To listen to the live webcast of the presentation, please visit the Events section of the company’s website at investors.zebra.com, where it will also be archived for replay.

WHO IS ZEBRA TECHNOLOGIES?

Zebra (NASDAQ: ZBRA) provides the foundation for intelligent operations with an award-winning portfolio of connected frontline, asset visibility and automation solutions powered by AI. Organizations globally across retail, manufacturing, transportation, logistics, healthcare, and other industries rely on us to deliver outcomes today while driving innovation for what’s next. Together with our partners, we create new ways of working that improve productivity and empower organizations to be better every day. Learn more at www.zebra.com.

Follow Zebra on our Blog, LinkedIn, Facebook, X, Instagram and YouTube.

ZEBRA and the stylized Zebra head are trademarks of Zebra Technologies Corporation, registered in many jurisdictions worldwide.All other trademarks are the property of their respective owners. ©2026 Zebra Technologies Corporation and/or its affiliates. All rights reserved.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260210916265/en/

Investor Contact:

Michael Steele, CFA, IRC

Vice President, Investor Relations

Phone: + 1 847 518-6432

[email protected]

Media Contact:

Therese Van Ryne

Senior Director, External Communications

Phone: + 1 847 370 2317

[email protected]

KEYWORDS: Illinois United States North America

INDUSTRY KEYWORDS: Professional Services Business Technology Software Artificial Intelligence Hardware

MEDIA:

Logo